Adult-to-Adult Living Donor Transplant Cohort Study
A2ALL: Adult-to-Adult Living Transplant Cohort Study
Sponsor: Arbor Research Collaborative for Health
This observational or N/A phase trial investigates End Stage Liver Disease and Hepatitis C and is currently completed. Arbor Research Collaborative for Health leads this study, which shows 12 recorded versions since 2011 — indicating substantial longitudinal coverage. As an oncology study, it adds to the longitudinal record of treatment development for this indication.
Change History
12 versions recorded-
Sep 2024 — Present [monthly]
Completed
-
Jul 2024 — Sep 2024 [monthly]
Completed
-
Dec 2021 — Jul 2024 [monthly]
Completed
-
Jan 2021 — Dec 2021 [monthly]
Completed
-
Nov 2020 — Jan 2021 [monthly]
Completed
▶ Show 7 earlier versions
-
Mar 2019 — Nov 2020 [monthly]
Completed
-
Jun 2018 — Mar 2019 [monthly]
Completed
-
May 2018 — Jun 2018 [monthly]
Completed
-
Apr 2018 — May 2018 [monthly]
Completed
Phase: NA → None
-
Sep 2017 — Apr 2018 [monthly]
Completed NA
Status: Unknown Status → Completed
-
Aug 2017 — Sep 2017 [monthly]
Unknown Status NA
-
Jan 2017 — Aug 2017 [monthly]
Unknown Status NA
First recorded
Feb 2011
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Arbor Research Collaborative for Health
- National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
For direct contact, visit the study record on ClinicalTrials.gov .
Study Locations
- • Aurora, United States
- • Burlington, United States
- • Chicago, United States
- • New York, United States
- • Philadelphia, United States
- • Pittsburgh, United States
- • Richmond, United States
- • San Francisco, United States
- • Toronto, Canada